1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neuroprotection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Free Anti-Inflammatory Agents
        1.2.3 Radical Trapping Agents (Antioxidants)
        1.2.4 Apoptosis Inhibitors
        1.2.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
        1.2.6 Neurotrophic Factors (NTFs)
        1.2.7 Stimulants
        1.2.8 Metal Ion Chelators
        1.2.9 Others
    1.3 Market by Application
        1.3.1 Global Neuroprotection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Prevention
        1.3.3 Treatment
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Neuroprotection Market Perspective (2017-2028)
    2.2 Neuroprotection Growth Trends by Region
        2.2.1 Neuroprotection Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Neuroprotection Historic Market Size by Region (2017-2022)
        2.2.3 Neuroprotection Forecasted Market Size by Region (2023-2028)
    2.3 Neuroprotection Market Dynamics
        2.3.1 Neuroprotection Industry Trends
        2.3.2 Neuroprotection Market Drivers
        2.3.3 Neuroprotection Market Challenges
        2.3.4 Neuroprotection Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Neuroprotection Players by Revenue
        3.1.1 Global Top Neuroprotection Players by Revenue (2017-2022)
        3.1.2 Global Neuroprotection Revenue Market Share by Players (2017-2022)
    3.2 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Neuroprotection Revenue
    3.4 Global Neuroprotection Market Concentration Ratio
        3.4.1 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neuroprotection Revenue in 2021
    3.5 Neuroprotection Key Players Head office and Area Served
    3.6 Key Players Neuroprotection Product Solution and Service
    3.7 Date of Enter into Neuroprotection Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroprotection Breakdown Data by Type
    4.1 Global Neuroprotection Historic Market Size by Type (2017-2022)
    4.2 Global Neuroprotection Forecasted Market Size by Type (2023-2028)
5 Neuroprotection Breakdown Data by Application
    5.1 Global Neuroprotection Historic Market Size by Application (2017-2022)
    5.2 Global Neuroprotection Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Neuroprotection Market Size (2017-2028)
    6.2 North America Neuroprotection Market Size by Type
        6.2.1 North America Neuroprotection Market Size by Type (2017-2022)
        6.2.2 North America Neuroprotection Market Size by Type (2023-2028)
        6.2.3 North America Neuroprotection Market Share by Type (2017-2028)
    6.3 North America Neuroprotection Market Size by Application
        6.3.1 North America Neuroprotection Market Size by Application (2017-2022)
        6.3.2 North America Neuroprotection Market Size by Application (2023-2028)
        6.3.3 North America Neuroprotection Market Share by Application (2017-2028)
    6.4 North America Neuroprotection Market Size by Country
        6.4.1 North America Neuroprotection Market Size by Country (2017-2022)
        6.4.2 North America Neuroprotection Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Neuroprotection Market Size (2017-2028)
    7.2 Europe Neuroprotection Market Size by Type
        7.2.1 Europe Neuroprotection Market Size by Type (2017-2022)
        7.2.2 Europe Neuroprotection Market Size by Type (2023-2028)
        7.2.3 Europe Neuroprotection Market Share by Type (2017-2028)
    7.3 Europe Neuroprotection Market Size by Application
        7.3.1 Europe Neuroprotection Market Size by Application (2017-2022)
        7.3.2 Europe Neuroprotection Market Size by Application (2023-2028)
        7.3.3 Europe Neuroprotection Market Share by Application (2017-2028)
    7.4 Europe Neuroprotection Market Size by Country
        7.4.1 Europe Neuroprotection Market Size by Country (2017-2022)
        7.4.2 Europe Neuroprotection Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Neuroprotection Market Size (2017-2028)
    8.2 Asia-Pacific Neuroprotection Market Size by Type
        8.2.1 Asia-Pacific Neuroprotection Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Neuroprotection Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Neuroprotection Market Share by Type (2017-2028)
    8.3 Asia-Pacific Neuroprotection Market Size by Application
        8.3.1 Asia-Pacific Neuroprotection Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Neuroprotection Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Neuroprotection Market Share by Application (2017-2028)
    8.4 Asia-Pacific Neuroprotection Market Size by Region
        8.4.1 Asia-Pacific Neuroprotection Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Neuroprotection Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Neuroprotection Market Size (2017-2028)
    9.2 Latin America Neuroprotection Market Size by Type
        9.2.1 Latin America Neuroprotection Market Size by Type (2017-2022)
        9.2.2 Latin America Neuroprotection Market Size by Type (2023-2028)
        9.2.3 Latin America Neuroprotection Market Share by Type (2017-2028)
    9.3 Latin America Neuroprotection Market Size by Application
        9.3.1 Latin America Neuroprotection Market Size by Application (2017-2022)
        9.3.2 Latin America Neuroprotection Market Size by Application (2023-2028)
        9.3.3 Latin America Neuroprotection Market Share by Application (2017-2028)
    9.4 Latin America Neuroprotection Market Size by Country
        9.4.1 Latin America Neuroprotection Market Size by Country (2017-2022)
        9.4.2 Latin America Neuroprotection Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Neuroprotection Market Size (2017-2028)
    10.2 Middle East & Africa Neuroprotection Market Size by Type
        10.2.1 Middle East & Africa Neuroprotection Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Neuroprotection Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Neuroprotection Market Share by Type (2017-2028)
    10.3 Middle East & Africa Neuroprotection Market Size by Application
        10.3.1 Middle East & Africa Neuroprotection Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Neuroprotection Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Neuroprotection Market Share by Application (2017-2028)
    10.4 Middle East & Africa Neuroprotection Market Size by Country
        10.4.1 Middle East & Africa Neuroprotection Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Neuroprotection Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 F. Hoffmann-La Roche
        11.1.1 F. Hoffmann-La Roche Company Details
        11.1.2 F. Hoffmann-La Roche Business Overview
        11.1.3 F. Hoffmann-La Roche Neuroprotection Introduction
        11.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2017-2022)
        11.1.5 F. Hoffmann-La Roche Recent Developments
    11.2 Eli Lilly and Company
        11.2.1 Eli Lilly and Company Company Details
        11.2.2 Eli Lilly and Company Business Overview
        11.2.3 Eli Lilly and Company Neuroprotection Introduction
        11.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2017-2022)
        11.2.5 Eli Lilly and Company Recent Developments
    11.3 Daiichi Sankyo Company
        11.3.1 Daiichi Sankyo Company Company Details
        11.3.2 Daiichi Sankyo Company Business Overview
        11.3.3 Daiichi Sankyo Company Neuroprotection Introduction
        11.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2017-2022)
        11.3.5 Daiichi Sankyo Company Recent Developments
    11.4 Allergan
        11.4.1 Allergan Company Details
        11.4.2 Allergan Business Overview
        11.4.3 Allergan Neuroprotection Introduction
        11.4.4 Allergan Revenue in Neuroprotection Business (2017-2022)
        11.4.5 Allergan Recent Developments
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Neuroprotection Introduction
        11.5.4 Novartis Revenue in Neuroprotection Business (2017-2022)
        11.5.5 Novartis Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Neuroprotection Introduction
        11.6.4 AstraZeneca Revenue in Neuroprotection Business (2017-2022)
        11.6.5 AstraZeneca Recent Developments
    11.7 Dr. Reddy's Laboratories
        11.7.1 Dr. Reddy's Laboratories Company Details
        11.7.2 Dr. Reddy's Laboratories Business Overview
        11.7.3 Dr. Reddy's Laboratories Neuroprotection Introduction
        11.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2017-2022)
        11.7.5 Dr. Reddy's Laboratories Recent Developments
    11.8 Astrocyte Pharmaceuticals
        11.8.1 Astrocyte Pharmaceuticals Company Details
        11.8.2 Astrocyte Pharmaceuticals Business Overview
        11.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction
        11.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2017-2022)
        11.8.5 Astrocyte Pharmaceuticals Recent Developments
    11.9 Teva Pharmaceutical Industries
        11.9.1 Teva Pharmaceutical Industries Company Details
        11.9.2 Teva Pharmaceutical Industries Business Overview
        11.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction
        11.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2017-2022)
        11.9.5 Teva Pharmaceutical Industries Recent Developments
    11.10 Biogen
        11.10.1 Biogen Company Details
        11.10.2 Biogen Business Overview
        11.10.3 Biogen Neuroprotection Introduction
        11.10.4 Biogen Revenue in Neuroprotection Business (2017-2022)
        11.10.5 Biogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Neuroprotection Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Free Anti-Inflammatory Agents
    Table 3. Key Players of Radical Trapping Agents (Antioxidants)
    Table 4. Key Players of Apoptosis Inhibitors
    Table 5. Key Players of Glutamate Antagonists (Anti-Excitotoxic Agents)
    Table 6. Key Players of Neurotrophic Factors (NTFs)
    Table 7. Key Players of Stimulants
    Table 8. Key Players of Metal Ion Chelators
    Table 9. Key Players of Others
    Table 10. Global Neuroprotection Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Neuroprotection Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Neuroprotection Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Neuroprotection Market Share by Region (2017-2022)
    Table 14. Global Neuroprotection Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Neuroprotection Market Share by Region (2023-2028)
    Table 16. Neuroprotection Market Trends
    Table 17. Neuroprotection Market Drivers
    Table 18. Neuroprotection Market Challenges
    Table 19. Neuroprotection Market Restraints
    Table 20. Global Neuroprotection Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Neuroprotection Revenue Share by Players (2017-2022)
    Table 22. Global Top Neuroprotection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotection as of 2021)
    Table 23. Ranking of Global Top Neuroprotection Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Neuroprotection Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Neuroprotection Product Solution and Service
    Table 27. Date of Enter into Neuroprotection Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Neuroprotection Revenue Market Share by Type (2017-2022)
    Table 31. Global Neuroprotection Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Neuroprotection Revenue Market Share by Type (2023-2028)
    Table 33. Global Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Neuroprotection Revenue Share by Application (2017-2022)
    Table 35. Global Neuroprotection Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Neuroprotection Revenue Share by Application (2023-2028)
    Table 37. North America Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Neuroprotection Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Neuroprotection Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Neuroprotection Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Neuroprotection Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Neuroprotection Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Neuroprotection Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Neuroprotection Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Neuroprotection Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Neuroprotection Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Neuroprotection Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Neuroprotection Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Neuroprotection Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Neuroprotection Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Neuroprotection Market Size by Country (2023-2028) & (US$ Million)
    Table 67. F. Hoffmann-La Roche Company Details
    Table 68. F. Hoffmann-La Roche Business Overview
    Table 69. F. Hoffmann-La Roche Neuroprotection Product
    Table 70. F. Hoffmann-La Roche Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 71. F. Hoffmann-La Roche Recent Developments
    Table 72. Eli Lilly and Company Company Details
    Table 73. Eli Lilly and Company Business Overview
    Table 74. Eli Lilly and Company Neuroprotection Product
    Table 75. Eli Lilly and Company Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 76. Eli Lilly and Company Recent Developments
    Table 77. Daiichi Sankyo Company Company Details
    Table 78. Daiichi Sankyo Company Business Overview
    Table 79. Daiichi Sankyo Company Neuroprotection Product
    Table 80. Daiichi Sankyo Company Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 81. Daiichi Sankyo Company Recent Developments
    Table 82. Allergan Company Details
    Table 83. Allergan Business Overview
    Table 84. Allergan Neuroprotection Product
    Table 85. Allergan Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 86. Allergan Recent Developments
    Table 87. Novartis Company Details
    Table 88. Novartis Business Overview
    Table 89. Novartis Neuroprotection Product
    Table 90. Novartis Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 91. Novartis Recent Developments
    Table 92. AstraZeneca Company Details
    Table 93. AstraZeneca Business Overview
    Table 94. AstraZeneca Neuroprotection Product
    Table 95. AstraZeneca Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 96. AstraZeneca Recent Developments
    Table 97. Dr. Reddy's Laboratories Company Details
    Table 98. Dr. Reddy's Laboratories Business Overview
    Table 99. Dr. Reddy's Laboratories Neuroprotection Product
    Table 100. Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 101. Dr. Reddy's Laboratories Recent Developments
    Table 102. Astrocyte Pharmaceuticals Company Details
    Table 103. Astrocyte Pharmaceuticals Business Overview
    Table 104. Astrocyte Pharmaceuticals Neuroprotection Product
    Table 105. Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 106. Astrocyte Pharmaceuticals Recent Developments
    Table 107. Teva Pharmaceutical Industries Company Details
    Table 108. Teva Pharmaceutical Industries Business Overview
    Table 109. Teva Pharmaceutical Industries Neuroprotection Product
    Table 110. Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 111. Teva Pharmaceutical Industries Recent Developments
    Table 112. Biogen Company Details
    Table 113. Biogen Business Overview
    Table 114. Biogen Neuroprotection Product
    Table 115. Biogen Revenue in Neuroprotection Business (2017-2022) & (US$ Million)
    Table 116. Biogen Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuroprotection Market Share by Type: 2021 VS 2028
    Figure 2. Free Anti-Inflammatory Agents Features
    Figure 3. Radical Trapping Agents (Antioxidants) Features
    Figure 4. Apoptosis Inhibitors Features
    Figure 5. Glutamate Antagonists (Anti-Excitotoxic Agents) Features
    Figure 6. Neurotrophic Factors (NTFs) Features
    Figure 7. Stimulants Features
    Figure 8. Metal Ion Chelators Features
    Figure 9. Others Features
    Figure 10. Global Neuroprotection Market Share by Application: 2021 VS 2028
    Figure 11. Prevention Case Studies
    Figure 12. Treatment Case Studies
    Figure 13. Neuroprotection Report Years Considered
    Figure 14. Global Neuroprotection Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Neuroprotection Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Neuroprotection Market Share by Region: 2021 VS 2028
    Figure 17. Global Neuroprotection Market Share by Players in 2021
    Figure 18. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotection as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Neuroprotection Revenue in 2021
    Figure 20. North America Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Neuroprotection Market Size Market Share by Type (2017-2028)
    Figure 22. North America Neuroprotection Market Size Market Share by Application (2017-2028)
    Figure 23. North America Neuroprotection Market Size Share by Country (2017-2028)
    Figure 24. United States Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Neuroprotection Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Neuroprotection Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Neuroprotection Market Size Share by Country (2017-2028)
    Figure 30. Germany Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Neuroprotection Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Neuroprotection Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Neuroprotection Market Size Share by Region (2017-2028)
    Figure 40. China Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Neuroprotection Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Neuroprotection Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Neuroprotection Market Size Share by Country (2017-2028)
    Figure 50. Mexico Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Neuroprotection Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Neuroprotection Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Neuroprotection Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Neuroprotection Market Size Share by Country (2017-2028)
    Figure 56. Turkey Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Neuroprotection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 60. Eli Lilly and Company Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 61. Daiichi Sankyo Company Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 62. Allergan Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 64. AstraZeneca Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 65. Dr. Reddy's Laboratories Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 66. Astrocyte Pharmaceuticals Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 68. Biogen Revenue Growth Rate in Neuroprotection Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed